- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05419895
Early Diagnostic Response Model (EDRM)
Early Diagnostic Response Model (EDRM): Evaluating an Early Screening to Evaluation Pilot Protocol for Children Identified as High Risk for Autism in 3 Pilot Early Intervention Health Districts
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to develop, pilot, and evaluate a diagnostic protocol to assess high-risk toddlers for autism spectrum disorder (ASD) diagnosis of families enrolled in the Georgia Babies Can't Wait (BCW) early intervention program. The Early Diagnostic Response Model (EDRM) project will be addressing children who are identified at high risk for ASD according to the BCW screening protocol, which is the M-CHAT-R/F. Community psychologist will be taught the protocol and receive referrals to build capacity and better address the need across the state. Currently, many children who are screening high-risk for ASD in BCW districts are unable to access follow-up evaluations due to limited community resources and long wait times. It is hypothesized that the EDRM will be successful in increasing the number of BCW families that access an ASD evaluation using telehealth tools and testing protocols and that the families and clinicians involved will be satisfied with the streamlined process. The clinicians' conclusions from the EDRM assessment will be based on the Diagnostic and Statistical Manual, 5th edition (DSM-5; American Psychiatric Association [APA], 2013) and are hypothesized to be able to provide high-risk children and their families with the same access to services as an in-person assessment.
A secondary objective is to investigate how many high-risk referral assessments can be completed entirely via streamlined telehealth protocol and how many required additional information to be collected to make a final DSM-5 conclusion.
A tertiary objective is to investigate the improvement of the EDRM as an early identification model to assess for ASD by comparing the numbers of families screened high risk for ASD and referred for an evaluation prior to the study to the number of families who received ASD evaluation by the end of the study through the pilot versus other means. These numbers will be analyzed globally as well as by specific BCW district and other child factors.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Allison Schwartz, PhD
- Phone Number: 404.727.8350
- Email: allison.schwartz@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory Autism Center
-
Contact:
- Allison Schwartz, PhD
- Phone Number: 404-727-8350
- Email: allison.schwartz@emory.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All families of children between the ages of 16-30 months of age who scored ≥8 on the MCHAT-R and whose BCW provider refers the child to our clinic by 33 months of age will be a possible participant. Evaluations will be done by 36 months of age.
- Referring BCW provider must be one of the three targeted BCW districts participating in this pilot study.
- Parent/Guardian needs to have basic English proficiency
- Parent/Guardian needs to have internet access
- Child must have exposure to English either at home or in out-of-home care (e.g., childcare setting).
- Documentation of M-CHAT-R High-Risk failed score (≥ 8) must be documented in referral.
Exclusion Criteria:
- Families making self-referrals to the EAC or referrals outside of the targeted BCW districts will be excluded from recruitment for this study.
- Children above the age of 33 months at the time of the referral will be excluded as the current EDRM protocol has not been developed in this phase of piloting for individuals over this age.
- Non-English speakers will be excluded from participation due to the current protocol not being applicable to their needs as well as a high correlation between verbal language abilities and social communication and social interaction (SCI) abilities as part of the DSM-5-TR autism criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Families with children enrolled in BCW with suspected diagnosis of autism
Post-consent, families with children between 16-33 months will receive a link to complete the EAC Developmental History Survey on REDCap and a link to complete parent/caregiver questionnaires about developmental and/or adaptive information.
Then, the family will be assigned to a clinician for the autism assessment and scheduled their assessment and feedback session (one week later).
|
Use of telehealth capabilities to implement measures and capture and code information related to an autism diagnosis.
This program evaluation will be using pre- and post-data and data collected through the process to evaluate the effectiveness of the EDRM pilot.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants referred to the Early Diagnostic Response Model (EDRM)
Time Frame: Until the end of the study (approximately one year)
|
Monthly numbers of high-risk referrals to the EDRM pilot project and total number of referrals made to the EDRM at the end of the study
|
Until the end of the study (approximately one year)
|
Number of participants consented in the Early Diagnostic Response Model (EDRM) study
Time Frame: Monthly until until the end of the study (approximately one year)
|
Monthly number of families referred who consent to EDRM participation
|
Monthly until until the end of the study (approximately one year)
|
Response rate in the Early Diagnostic Response Model (EDRM) study
Time Frame: Until end of the study (approximately one year)
|
Response rate will be calculated at project end using the formula [# of families who consented / # of families referred to project] x 100 = response rate)
|
Until end of the study (approximately one year)
|
Number of participants that completed the Early Diagnostic Response Model (EDRM) study
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year)
|
Quarterly numbers of participants that completed the EDRM assessment protocol and total number of participants who completed EDRM assessment protocol at study conclusion
|
Every 3 months (Quarterly) until end of study (approximately one year)
|
Time from referral to completion of the program
Time Frame: Up to 12 weeks post-intervention
|
Individual calculation of time from BCW referral to final summary report sent to family using the formula: Date of Final Report sent to family - Date of referral from BCW =Time in EDRM pilot |
Up to 12 weeks post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with additional information collected to make a final DSM-5 conclusion
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of participants with additional information collected to make a final DSM-5 conclusion
|
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Parent satisfaction of EDRM assessment survey
Time Frame: At completion of EDRM assessment (4 weeks post-intervention)
|
Administered at the end of individual EDRM assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 110. |
At completion of EDRM assessment (4 weeks post-intervention)
|
BCW provider(s) Service Coordinator satisfaction with EDRM assessment survey
Time Frame: At completion of EDRM assessment (4 weeks post-intervention)
|
Administered at end of individual EDRM assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 110. |
At completion of EDRM assessment (4 weeks post-intervention)
|
Parent satisfaction with access to treatment survey
Time Frame: 3 months after completion of EDRM assessment
|
Administered 3-months after completion of EDRM assessment. Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 15. |
3 months after completion of EDRM assessment
|
BCW provider(s) Early Intervention Coordinator satisfaction with EDRM pilot survey
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks postintervention
|
Completed every 3 months (Quarterly). Satisfaction surveys will use a Likert-scale of 1-5 with 1 being strongly disagree and 5 being strongly agree as well as 0 being not applicable/unknown. Higher scores indicate more satisfaction with specific aspect of EDRM project. Total score: 0 to 55 |
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks postintervention
|
Number of high-risk referral assessments that completed entirely via streamlined telehealth protocol
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of high-risk referral assessments that completed entirely via streamlined telehealth protocol, analyzed globally.
Monthly, Quarterly, and Total numbers of participants who completed EDRM pilot assessment.
|
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of of high-risk referral by BCW district
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of high-risk referral assessments by specific BCW district.
Monthly, Quarterly, and Total numbers of participants who completed EDRM pilot assessment.
|
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of of high-risk referral by child factors
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of high-risk referral assessments by child factors.
Monthly, Quarterly, and Total numbers of participants who completed EDRM pilot assessment.
|
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of of high-risk referral by clinician setting
Time Frame: Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of high-risk referral assessments by clinician setting.
Monthly, Quarterly, and Total numbers of participants who completed EDRM pilot assessment.
|
Every 3 months (Quarterly) until end of study (approximately one year), Up to 12 weeks post-intervention
|
Number of families screened high risk for ASD and referred for an evaluation
Time Frame: Through study completion, an average of 1 year
|
Number of families screened high risk for ASD and referred for an evaluation
|
Through study completion, an average of 1 year
|
Number of families who received ASD evaluation by the end of the study through the pilot versus other means
Time Frame: Through study completion, an average of 1 year
|
Number of families who received ASD evaluation by the end of the study through the pilot versus other means
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Allison Schwartz, PhD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003763
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All individual participant data collected during the EDRM pilot will be shared, after de-identification process has been completed.
Proposals may be submitted to up to 3 years following article publication. After 3 years, data will be provided in Emory University's data warehouse but without investigator support other than deposited materials.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Early Diagnostic Response Model (EDRM)
-
Duke UniversityUniversity of Cape TownCompletedAutism Spectrum DisorderSouth Africa
-
University Hospital, MontpellierCentre National de la Recherche Scientifique, FranceNot yet recruitingAutism Spectrum DisorderFrance
-
Maison Médicale Jeanne GarnierMinistry of Health, France; Centre hospitalier de l'Université de Montréal... and other collaboratorsRecruitingPalliative Care | Aged | Nursing HomesFrance
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingProstatic Neoplasms | Lymphatic MetastasisChina
-
Janssen Scientific Affairs, LLCCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Duke UniversityNational Institute of Mental Health (NIMH); University of Cape TownCompletedAutism Spectrum DisorderSouth Africa
-
Bar-Ilan University, IsraelAssociation for Children at RiskUnknown
-
University Hospital, MontpellierTerminatedAnalysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis PatientsCystic Fibrosis Patient | Patient Without Treatment Against A.FumigatusFrance
-
Hôpital le VinatierTerminatedAutism Spectrum DisorderFrance
-
Kakatiya UniversityCompletedComplication | Cardiac Event | Gender DiscriminationIndia